Author:
Zhu Zongdong,Hu Kaixin,Zhao Fengqing,Liu Wen,Zhou Hongkun,Zhu Zongliang,Li Huangbao
Abstract
Abstract
Background
This study aimed to investigate the risk factors for 30-day mortality in patients with malignant biliary obstruction (MBO) after endoscopic retrograde cholangiopancreatography (ERCP) with endobiliary metal stent placement. Furthermore, we aimed to construct and visualize a prediction model based on LASSO-logistic regression.
Methods
Data were collected from 245 patients who underwent their first ERCP with endobiliary metal stent placement for unresectable MBO between June 1, 2013, and August 31, 2021. Univariable and multivariable logistic regression analyses were conducted to identify the risk factors for 30-day mortality. We subsequently developed a logistic regression model that incorporated multiple parameters identified by LASSO regression. The model was visualized and the nomogram was plotted. Risk stratification was performed based on nomogram-derived scores.
Results
The 30-day mortality rate was 10.7% (23/245 patients). Distant metastasis, total bilirubin, post-ERCP complications, and successful drainage were independent risk factors of 30-day mortality. The variables screened by LASSO regression, including distant metastasis, total bilirubin, post-ERCP complications, and successful drainage, were incorporated into the logistic model. The results were visualized through a nomogram based on the model. To assess the model’s performance, discrimination was evaluated using the area-under-the-curve values obtained from receiver operating characteristic analyses with 10-fold cross-validation in the training group and validated in the testing group. The calibration curve showed the good predictive ability of the model. Decision curve analysis is used to evaluate the clinical application of nomogram. Finally, we performed risk stratification based on the risk calculated using the nomogram. Patients were assigned to the low-, moderate-, and high-risk groups based on their probability scores. The Kaplan–Meier survival curves for the different nomogram-based groups were significantly different (p < 0.001).
Conclusions
We developed a nomogram using the LASSO-logistic regression model to forecast the 30-day mortality rate in patients who had undergone ERCP with endobiliary metal stent placement due to MBO. This nomogram can assist in identifying individuals at high-risk of 30-day mortality following ERCP.
Funder
Science and Technology Project of Zhejiang Medical and Health
Key Discipline of Hepatobiliary and Pancreatic Surgery of Jiaxing City
Translational therapy center for hepatobiliary pancreatic cancer
Science and technology project of Jiaxing
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Tsuyuguchi T, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Suyama M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Amano H, Miura F. Japanese association of biliary surgery; Japanese society of hepato-biliary-pancreatic surgery; Japan society of clinical oncology. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. J Hepatobiliary Pancreat Surg. 2008;15(1):69–73. https://doi.org/10.1007/s00534-007-1282-x.
2. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002;56(6):835–41. https://doi.org/10.1067/mge.2002.129868.
3. Malangoni MA, McCoy DM, Richardson JD, Flint LM. Effective palliation of malignant biliary duct obstruction. Ann Surg. 1985;201(5):554–9. https://doi.org/10.1097/00000658-198505000-00003.
4. Pereira-Lima JC, Jakobs R, Maier M, Kohler B, Benz C, Martin WR, Riemann JF. Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Hepatogastroenterology. 1996;43(10):944–8.
5. Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97(4):898–904. https://doi.org/10.1111/j.1572-0241.2002.05606.x.